ABLE is celebrating its 19th Anniversary along with the annual BioEconomy Conclave 2022 on 22nd March 2022, from 11 am to 6 pm, as a physical event at The TAJ MG Road (Trinity Hall). We have decided to have this physical event especially after the Pandemic fading away and the need for the Biotech segment to not only acknowledge the contributions of this segment in addressing this pandemic but also plan for the future.
The BioEconomy Conclave will provide a first-hand opportunity to biotech leaders to interact with the new Department of Biotechnology(DBT) Secretary, On this occasion, we have decided to showcase the impressive strides made by the biotech industry in recent years in different segments, voice the need for some key policy and regulatory changes that will make the path smoother for the industry’s march towards the $ 100 billion mark by 2025.
Venue : Taj MG Road, Bangalore
Date : March 22, 2022.
Though India is the land of 1.3 billion human genomes and the subcontinent contributes around 20% of the world's population, the DNA sequences of Indian people make up around 0.2% of global genetic databases. A lot has to be achieved.
There has been path-breaking work in using genomics. Few hospitals have been using genetic information to help patients. But all of this activity is on a much smaller scale. What is needed is a coherent push at the national level that involves government, academic institutions, the existing health-care industry, the IT industry and the nascent biotechnology industry.
A sustainable approach for cleaner environment is the order of the day. Having said, this is a tough ask considering the diverse areas of significance from BioEnergy to Green Industrial Biotech to Pure water and air.
Biofuels and Green Industrial biotech can help solve climate change. Further, an integrated approach is needed for sustainable developments.
India is fast developing its Medtech capabilities that have begun to gain global attention. With almost 80% of the medical devices imported from other countries India has an interesting journey ahead.
CSIR’s Institute of Genomics & Integrative Biology (CSIR-IGIB) has a set of over 27 genetics tests it has developed over the years that can be commercialized. There are various other institutes which have worked on various technologies from healthcare to food testing.
This panel will discuss:
Reports suggest that 15% of Indian population is undernourished. Nutritional security is an important aspect that needs immediate attention.
Why India needs Biotechnology to ensure food, feed, and nutrition security?
AMR has caught worldwide attention and needs an urgent solution. With a large population and heavy disease burden India needs to redoube its efforts to safegaurd its citizens.
India is fast becoming a center for Innovation hotspots. Cities like Bangalore, Chennai, Pune, Hyderabad and several others are supporting the start-up ecosystems. The Public sector has been a major facilitator at the National and State levels.
India’s premier institutes and scientific Institutes are taking the incubation route.
NCDs are a major cause of India's disease burden. India is already the diabetic capital of the World and the situation could be similar soon in the other diseases as well.
According a recent report of ICMR NCDs and suicide have been on the rise. The report says cardiovascular diseases, diabetes, chronic respiratory diseases, cancer, and suicide prevalences have gone up drastically.